IRVINE, Calif.--(BUSINESS WIRE)--MiCardia Corporation today announced that The United States Patent Office granted patent number 8,821,570, “Adjustable Annuloplasty Ring with Subcutaneous Activation Port,” on September 2, 2014.
This patent and its execution can allow for minimally invasive or percutaneous access to activate a device implanted into the cardiovascular system. MiCardia developed this vascular access delivery system to use with its enCorSQ Mitral Valve Repair SystemTM. This access port may also be clinically beneficial for the delivery and use of a number of other implantable cardiovascular devices.
Help employers find you! Check out all the jobs and post your resume.
